I am a senior research fellow at the Centre for Eye Research Australia (CERA), working with Dr. Thomas Edwards in the Retinal Gene Therapy Unit. My research spans extracellular vesicles/exosomes, retinal neurodegenerative diseases, mitochondrial dysfunction, and translational gene therapy approaches.
My doctoral work was focused on the biology of cancer exosomes. I developed expertise in exosomes biology, which I now apply to retinal gene therapy and neurodegenerative eye diseases. Following my PhD, I undertook postdoctoral research at Monash University, where I gained experience in structural immunology and protein biology.
Since joining CERA in 2020, I have been developing an independent research program applying my exosome expertise to retinal gene therapy, focusing on non-viral delivery strategies for therapeutic molecules. My goal is to generate high-quality preclinical evidence to address critical knowledge gaps in retinal therapeutics, ultimately contributing to novel interventions for blinding diseases.
I have authored 19 peer-reviewed journal articles, including 8 as first author and one as senior author, with ~2,938 citations. I have also secured competitive funding as Chief Investigator, including philanthropic and institutional grants. I actively contribute to mentorship and leadership. I have supervised honours students, PhD students, and research assistants, including students with disabilities, fostering inclusive training environments.
I am a senior research fellow at the Centre for Eye Research Australia (CERA), working with Dr. Thomas Edwards in the Retinal Gene Therapy Unit. My research spans extracellular vesicles/exosomes, retinal neurodegenerative diseases, mitochondrial dysfunction, and translational gene therapy approaches.
My doctoral work was focused on the biology of cancer exosomes. I developed expertise in exosomes biology, which I now apply to retinal gene therapy and neurodegenerative eye diseases. Following my PhD, I undertook postdoctoral research at Monash University, where I gained experience in structural immunology and protein biology.
Since joining CERA in 2020, I have been developing an independent research program applying my exosome expertise to retinal gene therapy, focusing on non-viral delivery strategies for therapeutic molecules. My goal is to generate high-quality preclinical evidence to address critical knowledge gaps in retinal therapeutics, ultimately contributing to novel interventions for blinding diseases.
I have authored 19 peer-reviewed journal articles, including 8 as first author and one as senior author, with ~2,938 citations. I have also secured competitive funding as Chief Investigator, including philanthropic and institutional grants. I actively contribute to mentorship and leadership. I have supervised honours students, PhD students, and research assistants, including students with disabilities, fostering inclusive training environments.